“Immune mechanisms in fibrotic pulmonary sarcoidosis”. P. Weeratunga, D.R. Moller and L-P. Ho. Eur Respir Rev 2022; 31: 220178

Similar Items

• “Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022.
  Published: (2019-11-01)
• “Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.” Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630–641.
  Published: (2016-03-01)
• “Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.” Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630–641.
  Published: (2017-01-01)
• “Intersections of lung progenitor cells, lung disease and lung cancer.” Carla F. Kim. Eur Respir Rev 2017; 26: 170054.
  Published: (2017-10-01)
• “Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051.
  Published: (2020-02-01)